Analysis

Important takeaways from IBM’s first-quarter 2024 earnings report

International Business Machines Corporation (NYSE: IBM) this week reported mixed results for the first three months of fiscal 2024, with earnings beating

Snap (SNAP): Four noteworthy points from the Q1 earnings report

Shares of Snap Inc. (NYSE: SNAP) jumped 30% on Friday, a day after the company delivered strong results for the first quarter

Southwest Airlines (LUV): Factors that clouded the airline’s Q1 performance

Shares of Southwest Airlines Co. (NYSE: LUV) plummeted on Thursday after the company missed expectations on its first quarter 2024 earnings results.

Interviews

AlphaStreet's dedicated Earnings Call section is your one-source destination for all publicly listed earnings conference calls. Listen to CEOs/CFOs discuss their company's earnings reports while Wall Street Analysts ask (or grill) with their hard hitting questions.

Most Read

CVX Earnings: Chevron reports lower revenue and profit for Q1 2024

Energy exploration company Chevron Corporation (NYSE: CVX) announced first-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation was $5.50 billion or

April 26, 2024

ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up

Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues. The company reported worldwide net

April 26, 2024

CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results

Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today. Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%. Net income attributable to Colgate-Palmolive Company was

April 26, 2024

Research Summary

Ocean Biomedical, Inc. (NASDAQ: OCEA) Research Summary

Ocean Biomedical, Inc. (NASDAQ: OCEA) is a biotechnology company that works with leading researchers

Trxade Health Inc. (NASDAQ: MEDS) Q4 2023 Research Summary

Trxade Health, Inc. (NASDAQ: MEDS) operates as an integrated drug procurement and delivery platform,

Viewing Highlight
Loading...
Highlight
Close
Top